Cargando…
Editorial: Response assessment of radioligand therapies
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364693/ https://www.ncbi.nlm.nih.gov/pubmed/35965585 http://dx.doi.org/10.3389/fonc.2022.904337 |
| _version_ | 1784765198237696000 |
|---|---|
| author | Lopci, Egesta Prasad, Vikas |
| author_facet | Lopci, Egesta Prasad, Vikas |
| author_sort | Lopci, Egesta |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9364693 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93646932022-08-11 Editorial: Response assessment of radioligand therapies Lopci, Egesta Prasad, Vikas Front Oncol Oncology Frontiers Media S.A. 2022-07-27 /pmc/articles/PMC9364693/ /pubmed/35965585 http://dx.doi.org/10.3389/fonc.2022.904337 Text en Copyright © 2022 Lopci and Prasad https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Oncology Lopci, Egesta Prasad, Vikas Editorial: Response assessment of radioligand therapies |
| title | Editorial: Response assessment of radioligand therapies |
| title_full | Editorial: Response assessment of radioligand therapies |
| title_fullStr | Editorial: Response assessment of radioligand therapies |
| title_full_unstemmed | Editorial: Response assessment of radioligand therapies |
| title_short | Editorial: Response assessment of radioligand therapies |
| title_sort | editorial: response assessment of radioligand therapies |
| topic | Oncology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364693/ https://www.ncbi.nlm.nih.gov/pubmed/35965585 http://dx.doi.org/10.3389/fonc.2022.904337 |
| work_keys_str_mv | AT lopciegesta editorialresponseassessmentofradioligandtherapies AT prasadvikas editorialresponseassessmentofradioligandtherapies |